Author:
Jourdain Gonzague,Le Cœur Sophie,Ngo-Giang-Huong Nicole,Traisathit Patrinee,Cressey Tim R.,Fregonese Federica,Leurent Baptiste,Collins Intira J.,Techapornroong Malee,Banchongkit Sukit,Buranabanjasatean Sudanee,Halue Guttiga,Nilmanat Ampaipith,Luekamlung Nuananong,Klinbuayaem Virat,Chutanunta Apichat,Kantipong Pacharee,Bowonwatanuwong Chureeratana,Lertkoonalak Rittha,Leenasirimakul Prattana,Tansuphasawasdikul Somboon,Sang-a-gad Pensiriwan,Pathipvanich Panita,Thongbuaban Srisuda,Wittayapraparat Pakorn,Eiamsirikit Naree,Buranawanitchakorn Yuwadee,Yutthakasemsunt Naruepon,Winiyakul Narong,Decker Luc,Barbier Sylvaine,Koetsawang Suporn,Sirirungsi Wasna,McIntosh Kenneth,Thanprasertsuk Sombat,Lallemant Marc,
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies;M Egger;Lancet,2002
2. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel;MA Thompson;JAMA,2010
3. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies;Lancet,2008
4. Panel on Antiretroviral Guidelines for Adults and Adolescents (2011). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington (D.C.): Department of Health and Human Services. October 14, 2011. pp. 1–167.
5. World Health Organization (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. June 2013. Geneva: WHO.